Trevena to Present at the JMP Securities Life Sciences Conference
09 June 2021 - 9:00PM
Trevena, Inc. (TRVN), a biopharmaceutical company focused on the
development and commercialization of novel medicines for patients
with central nervous system (CNS) disorders, today announced that
Carrie Bourdow, President and Chief Executive Officer of Trevena,
Inc. will participate in a fireside chat at the JMP Securities Life
Sciences Conference being held virtually June 16 - 17, 2021.
Presentation Details |
Date: |
Wednesday, June 16, 2021 |
Time: |
1:30 pm Eastern Time |
Presenter: |
Carrie Bourdow, President & CEO |
Webcast: |
https://wsw.com/webcast/jmp49/trvn/1718600 |
A link to the webcast will be available on the Events page of
the Investors section of the Company’s website at
https://www.trevena.com/investors/events-presentations/ir-calendar.
A replay of the presentation will be archived on the website and
available for approximately 30 days following the event. Please
contact your JMP Securities representative to schedule virtual
one-on-one meetings with Trevena during the conference.
About Trevena
Trevena, Inc. is a biopharmaceutical company focused on the
development and commercialization of innovative medicines for
patients with CNS disorders. The Company has one approved product
in the United States, OLINVYK® (oliceridine) injection, indicated
in adults for the management of acute pain severe enough to require
an intravenous opioid analgesic and for whom alternative treatments
are inadequate. The Company’s novel pipeline is based on Nobel
Prize winning research and includes four differentiated
investigational drug candidates: TRV250 for the acute treatment of
migraine, TRV734 for maintenance treatment of opioid use disorder,
TRV045 for diabetic neuropathic pain and epilepsy, and TRV027 for
acute respiratory distress syndrome and abnormal blood clotting in
COVID-19 patients.
For more information, please visit www.Trevena.com.
Investor Contact:
Daniel FerryLifeSci AdvisorsPhone: 617-430-7576Email:
IR@trevena.com
Company Contact:
Sasha BennettDirectorClyde
GroupSasha.Bennett@clydegroup.com(239) 248-3409
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Apr 2024 to May 2024
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From May 2023 to May 2024